Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
Last edited:
According to the dictionary the word "safe" means:
1. secure from liability to harm, injury, danger, or risk: a safe place.
2. free from hurt, injury, danger, or risk: to arrive safe and sound.
3. involving little or no risk of mishap, error, etc.: a safe estimate.
Given the situation, I don't think anything has been misrepresented. Yes, with Ox/AZ there was a risk of a serious kind of clotting, and that was made public as soon as it was found, and policy was changed. And for the mRNA vaccines there are various complications, the main one being heart inflammation, but again that's not being hidden, and in a few countries that's been part of the reason for changing policy (giving doses 8 weeks or so apart rather than 3).Then yes, provided people are made aware of this before using the product then this may be acceptable to them.
That's how I feel. Sure, last January the vaccines were new (and the mRNA ones seemed very new (though based on decades of work)) and the disease was also new (so maybe it'll disappear in the summer, for example).I respect other people's wish not to be vaccinated, but I don't really understand it.
I'm all for transparency, but is this actually providing any meaningful new evidence? Hundreds of millions of people have had this vaccine, and we can just look at what happened to them (through the yellow card and similar systems for short term effects, and a number of countries have, I'm sure, been tracking too).The reason you don't think anything has been misrepresented, is because it wasn't presented to begin with. It took some persistant doctors and a court judge for that to happen.
Here's another YouTube video on the documents, recorded a few days before Campbell's but apparently covering the same sorts of misunderstandings. False Claims about Pfizer documentI'm all for transparency, but is this actually providing any meaningful new evidence?
But looking at the data now, doesn't it look clear that the vaccines are effective enough relative to their (small) risks?The injections used against Covid did not have such long term data and so it was always a judgement call to balance the risks of having the jab against the risk of the disease itself, especially as the Covid jab has proven not to be particularly effective.
I don't mean to imply that "unhealthy" adults don't matter. (Obviously, since I am one.) I'm just assuming that "healthy" adults are less likely to suffer much from infection. (And now there's a reasonable understanding of what comorbidities are relevant, though less so for long COVID.)but there are surely enough reports of healthy adults
Did you have a look at the (much shorter) video I linked to? She says this document has been available since November 17, 2021. So presumably long after he had his vaccinations, but still a while ago. She notes it's not for 46,000 participants (rather, it includes everyone who'd been given the vaccination), that there aren't 9 pages of adverse events (rather, those are the possible events they were particularly looking for), and that it wasn't sealed until 2097 (the FOI resulted in hundreds of thousands of pages and the FDA was able to release only 500 pages a month (they needed to redact for trade secret and patient confidentiality reasons), and offered to prioritise according to the requestors wishes; a court order required them to speed that up, so the FDA is apparently hiring more people to do the checking and redacting)).The question Campbell also raised in his video is the lack of transparency and the effect this has on people being able to make informed decisions. He's clearly upset that this information wasn't given to him (or others).
Here (again) is the UK information: https://www.gov.uk/government/publi...irus-vaccine-summary-of-yellow-card-reportingWhat are the figures for injuries, hospitalisation, disabilities and deaths to date?
I'm not aware of particular concerns. For Ox/AZ it seemed to be that if you don't get the clotting reaction from the first dose the second dose would be safe, but I'm not sure there were enough cases to be confident before we pretty much stopped using it. For the two mRNA vaccines I think several countries are separating the doses by more than 4 weeks because it's felt that reduces the chance or severity of myocarditis (which is usually described as mild and short lived).For the first 3 months in the UK that data could be relevant to only 1 jab, what about the other 2,3,4 etc since, what is the cumalitive affects?
That was studied for the UK's booster doses in the COV-BOOST study, published here https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02717-3/fulltextWhat are the mixing effects between combining different manufacturers?
As far as I know it's regarded as positive. The suggestion is that the 3 (or 4) week separation was to get trial results as soon as possible (and is to maximise the protection available short term) rather than because it was ideal. I've heard people suggesting that if we weren't in a pandemic then maybe just two doses 6 months apart might do as well as 2 doses 3 weeks apart followed by another one 6 months later. But we still have really high prevalence, so getting people good protection as fast as possible is still important.What are the effects of not following the manufacturers guidance on timings between doses?
It would mean never having new vaccines for anything. Who could afford to test a vaccine on millions of people over many years?Chris, that would make for a good definition of "vaccine".
If you mean you want a vaccine that provides perfect immunity against something, then there's never going to be a vaccine. No vaccines provide complete immunity.I wasn't suggesting this would be how trials are done, just that if something eradicates the thing you are fighting against and it is proven over time, this gives one confidence in them and certainly meets the (original) definition of vaccine.
Not true. Where are you getting this nonsense? There were exclusions (women who were or were intending to become pregnant is an obvious one), but there were certainly old participants and people with various coexisting conditions. The Pfizer trial was published here and gives the participant ages as 16-91, with median 52.0. Yes, that includes lots of people who aren't the people we most care about vaccinating, but that doesn't seem a bad choice.The other thing I noticed in the trials was they were carried out only on the middle age groups on only healthy people.
Because there was good reason to think they would be safe in humans (as they in fact were), so the animal trials happened alongside the human ones. fullfactAs we know, the vaccines were not tested on animals before they were tested on humans.
Paralytic poliomyelitis only affected 0.1-0.5% (1-5% nonparalytic aseptic meningitis). Hardly seems worrying about, does it? The arguments you (and your sources) are using are ones that have always been used against vaccines.As I said before, the absolute benefit of a vaccine for covid is around 1% and many people already had a 99% chance of survival with either their innate immunity or cross transferred prior immunity from other viruses.
It would certainly be good to know the longterm risks from infection. Unfortunately we just don't know for this novel virus though it looks like some people who get significantly sick can have serious longterm disability, and some who have an apparently mild infection can still be suffering long after it.So to put this into context of the released papers and the number of subsequent health problems, you need to evaluate the benefit to risk based on things we know.
This is a preprint (so hasn't been peer reviewed yet), and it doesn't seem that I can read the actual paper (though that might be a browser issue).New paper from editor of the British Medical Journal on trials.
The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials (2.3 and 6.4 per 10,000 participants, respectively).
Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials
Introduction: In 2020, prior to COVID-19 vaccine rollout, the Coalition for Epidemic Preparedness Innovations and Brighton Collaboration created a priority listpapers.ssrn.com
Yes, I can see the paper now (different browser at home). I still doubt the value of comparing these SAEs against how well the vaccines reduce hospitalisations over the course of the trial. The vaccines are for years (if not decades) not just for a few months, which makes it (to me) an unhelpful comparison.No, they only looked at serious adverse events.